Elevated stromal chondroitin sulfate glycosaminoglycan predicts progression in early-stage prostate cancer

Carmela Ricciardelli; Keiko Mayne; Pam Sykes; Wendy Raymond; Kieran McCaul; Villis Marshall; Wayne Tilley; John Skinner; David Horsfall

Elevated stromal chondroitin sulfate glycosaminoglycan predicts progression in early-stage prostate cancer

Carmela Ricciardelli
, Keiko Mayne
, Pam Sykes
, Wendy Raymond
, Kieran McCaul
, Villis Marshall
, Wayne Tilley
, John Skinner
, David Horsfall

Research output: Contribution to journal › Article › peer-review

86 Citations (Scopus)

Original language	English
Pages (from-to)	983-992
Number of pages	10
Journal	Clinical Cancer Research
Volume	3
Publication status	Published - 1997

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{ff54313f6a3844d0aac57c74d7fad487,

title = "Elevated stromal chondroitin sulfate glycosaminoglycan predicts progression in early-stage prostate cancer",

author = "Carmela Ricciardelli and Keiko Mayne and Pam Sykes and Wendy Raymond and Kieran McCaul and Villis Marshall and Wayne Tilley and John Skinner and David Horsfall",

year = "1997",

language = "English",

volume = "3",

pages = "983--992",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research",

}

TY - JOUR

T1 - Elevated stromal chondroitin sulfate glycosaminoglycan predicts progression in early-stage prostate cancer

AU - Ricciardelli, Carmela

AU - Mayne, Keiko

AU - Sykes, Pam

AU - Raymond, Wendy

AU - McCaul, Kieran

AU - Marshall, Villis

AU - Tilley, Wayne

AU - Skinner, John

AU - Horsfall, David

PY - 1997

Y1 - 1997

M3 - Article

SN - 1078-0432

VL - 3

SP - 983

EP - 992

JO - Clinical Cancer Research

JF - Clinical Cancer Research

ER -